This Jmol page shows the structure of HIV protease bound to an inhibitor (HIV drug). In this complex, a number of non-polar residues of the protease make extensive contacts the inhibitor, providing a hydrophobic binding pocket that stabilizes the drug-enzyme complex. The presence of the drug in the active site prevents the protease from binding its normal substrate.